Second-Quarter Revenue Grew 279% Year-Over-Year; Increased FY2026 Outlook
Demonstrated Near Five-Nines Logical Fidelity on Helios, Extending Leadership in Fault Tolerance
Announced Industry-First Partnership with Oracle to Deploy Helios as an Oracle Cloud Infrastructure (OCI) Service
Strengthened Supply Chain Through Strategic Collaboration with Major Global Electronics Manufacturer
BROOMFIELD, Colo., Aug. 11, 2026 /PRNewswire/ -- Quantinuum Inc. (Nasdaq: QNT) (the "Company"), a leading quantum computing company, today announced financial results for the second quarter ended June 30, 2026.
"Our second quarter performance demonstrated strong execution against our strategy. We delivered critical R&D breakthroughs to advance our platform roadmap and enhance our competitive position, strengthened our supply chain and manufacturing capabilities, and increased our developer ecosystem engagement," said Rajeeb Hazra, President and CEO of Quantinuum. "As a result, we are seeing accelerating commercial momentum for the business, reflected in the second quarter results and the improved full-year outlook. With over $2 billion in cash, we have the capability to invest to accelerate our business plans, while maintaining a disciplined approach to capital allocation to ensure sustainable long-term growth and profitability."
Second Quarter 2026 Financial Highlights
-- Completed industry's first traditional initial public offering, raising
$1.7 billion in gross proceeds
-- Revenue was $8 million, +279% year-over-year, versus $2 million in the
prior-year period
-- GAAP gross margin was (64.4%), up 27 percentage points versus the
prior-year period
-- Adjusted gross margin was 62%, down 60 basis points versus the prior-year
period
-- GAAP net loss was $597 million, compared with a net loss of $57 million
in the prior-year period
-- Adjusted EBITDA loss was $68 million, compared with a loss of $43 million
in the prior-year period
-- GAAP net loss per share attributable to Class A common stockholders was
$1.93
-- Adjusted net loss per share was $0.28
-- Cash & cash equivalents, and short-term investments were $2.1 billion as
of June 30, 2026
Adjusted EBITDA, Adjusted Gross Margin and Adjusted net loss per share are non-GAAP financial measures defined under "Non-GAAP Financial Measures." For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, refer to the Appendix tables at the end of this press release.
Second Quarter and Recent Business Highlights
Commercial Highlights
-- Announced an industry-first strategic partnership with Oracle to deploy
Helios on Oracle Cloud Infrastructure's (OCI) AI data center to enable
hybrid quantum-AI workloads as an OCI service. By operating on-premises
within OCI's infrastructure, Helios is anticipated to be able to
integrate seamlessly with existing OCI compute, networking, storage,
identity, and data services under the same governance and access controls
customers already use.
-- Announced strategic collaboration with HPE to establish a framework for
combining quantum computing with HPC and AI environments and engage
enterprise customers on hybrid quantum-classical solutions for high-value
scientific and industrial use cases.
R&D Milestones
Product Technology and Supply Chain
-- Demonstrated industry-leading near five-nines logical fidelity on Helios,
with a novel QEC code family, reinforcing Quantinuum's leadership in
fault tolerance.
-- Progressing towards the launch of Sol in 2027, with Sol's trap chip back
from fabrication and advancing through product validation.
-- Apollo remains on schedule for 2029, with significant progress made
across key architectural subsystems through prototyping.
-- Signed a new joint development agreement with a leading global
electronics manufacturer to co-develop the infrastructure, systems
engineering, and manufacturing capabilities required for future
generations of quantum computers.
-- Entered into a letter of intent with the U.S. Department of Commerce's
CHIPS R&D Office to strengthen onshore supply chains and accelerate U.S.
leadership in trapped-ion quantum computing.
Ecosystem
-- Accelerated Nexus adoption, with 180 organizations now using the
cloud-based developer platform to build new quantum applications.
-- Launched Guppy Playpond, a frictionless web-based environment set up for
developers to learn writing and testing code in Guppy, to increase
adoption of this next-generation quantum programming language.
-- Expanded the Quantinuum Startup Partner Program with Qedma, integrating
its error suppression and mitigation software into Quantinuum's Nexus
platform, giving enterprise and scientific users an additional
optimization layer that can improve accuracy for large, complex
workloads.
Application Research
-- Invented a new parallel quantum phase-estimation algorithm for faster and
more precise determination of molecular properties, with broad
applications including pharmaceuticals, life-sciences, and energy.
-- Demonstrated, with NVIDIA and a Fortune 100 pharma company, how AI-driven
quantum simulation can potentially enhance molecular property
characterization in pharmaceutical applications.
-- Simulated complex magnetic materials with accuracy beyond the practical
capabilities of the most advanced classical computers, with applicability
to improving maglev and MRI systems.
Financial Outlook
-- Establishing first formal guidance as a public company, with 2026 revenue
expected to be in the range of $28 to $32 million.
Second Quarter 2026 Conference Call
Quantinuum will host a conference call at 5 PM Eastern time on Tuesday, August 11, 2026, to discuss its results for the second quarter ended June 30, 2026, and provide a business update. The call will be available live via webcast here.
An archived replay of the webcast will be made available on the Quantinuum Investor Relations website following the call and will remain available for one year.
Non-GAAP Financial Measures
To supplement Quantinuum's condensed consolidated financial statements presented in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company uses the following non-GAAP financial measures presented in this release: Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Net Loss, fully distributed, Adjusted EBITDA, and Adjusted Net Loss Per Share, fully distributed.
Adjusted Gross Profit starts with GAAP gross profit and adds back equity compensation and related employer taxes attributable to cost of revenue and depreciation and amortization attributable to cost of revenue.
Adjusted Gross Margin is calculated as Adjusted Gross Profit divided by revenue, net.
Adjusted Net Loss, fully distributed starts with GAAP net loss on an as-converted basis, adds back GAAP income tax expense, adjusts for equity compensation and related employer taxes, costs of the initial public offering and the transition to public company reporting, the change in fair value of liability-classified warrants, and loss on disposal and write down of assets, and then applies an assumed statutory tax rate to the resulting adjusted pre-tax loss. No tax benefit is recognized in respect of losses subject to a full valuation allowance, and accordingly no tax benefit is reflected in the periods presented.
Adjusted EBITDA starts with Adjusted Net Loss, fully distributed, and further excludes interest income, net, depreciation, and amortization of acquired intangibles.
Adjusted Net Loss Per Share, fully distributed is calculated as Adjusted Net Loss, fully distributed, divided by adjusted shares, fully distributed, basic and diluted, comprising weighted-average Class A common shares outstanding and Common Units of Quantinuum Holdings.
Management believes these measures provide investors with additional information useful in evaluating the Company's operating performance and trends across periods. Quantinuum's results include large non-cash charges that do not reflect the cost of operating the business in the period, principally stock-based compensation recognized on completion of the Reorganization and remeasurement of liability-classified warrants. Both are driven by accounting triggers and external inputs rather than operating activity. As an early commercial-stage business, Quantinuum's period-to-period results also are affected by the timing of individual contracts. Measures that isolate underlying operating performance from non-cash and transition items help investors assess trends across periods.
Quantinuum's Up-C structure means that GAAP net loss attributable to Quantinuum Inc. reflects only the Class A share of the economics. Presenting adjusted results on an as-converted, fully distributed basis describes the whole economic enterprise, which is how management assesses performance and how the business is managed. Management uses these measures for internal planning and forecasting, evaluating operating performance, and preparing budgets.
These non-GAAP financial measures are supplemental and are not prepared in accordance with GAAP. They are not intended to be considered in isolation or as a substitute for the most directly comparable financial information prepared in accordance with GAAP. Quantinuum's non-GAAP measures may differ from similarly titled measures used by other companies and, therefore, may not be comparable. Investors should review the reconciliations and should not rely on any single financial measure to evaluate the Company's business.
Each non-GAAP financial measure is reconciled to its most directly comparable GAAP financial measure in the tables at the end of this release.
About Quantinuum
Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry's highest accuracy levels based on average two-qubit gate fidelity.([1]) Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally. The company has a global workforce of approximately 800 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master's degrees. Quantinuum's headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore. For more information, please visit www.quantinuum.com.
Availability of Information on Quantinuum's Website
Investors and others should note that Quantinuum routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Quantinuum Investor Relations website. While not all of the information that the Company posts to the Quantinuum Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Quantinuum to review the information that it shares on ir.quantinuum.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of Quantinuum's management and are subject to significant risks and uncertainties. Actual results may differ materially from those described in the forward-looking statements. Any statements made in this press release that are not statements of historical fact, including statements about our beliefs, expectations and outlook are forward-looking statements. Forward-looking statements include information concerning possible or assumed future results of operations, including our guidance and descriptions of our business plans and strategies. These statements often include words such as "anticipate," "expect," "guidance," "suggest, " "plan," "believe," "intend," "estimate," "target," "project," "should, " "could," "would," "may," "will," "forecast," "outlook," "potential," "continues," "seeks," "predicts," or the negatives of these words and other similar expressions.
Factors that could cause actual results to differ materially from those described in forward-looking statements include, but are not limited to: our ability to develop, commercialize and achieve market acceptance of our quantum computing hardware and software products; the pace of development of the quantum computing industry and the timing of commercial quantum advantage; our ability to attract and retain customers for our quantum computing systems and quantum computing as a service offerings; the risk of technological obsolescence or the emergence of competing quantum computing approaches, including superconducting, photonic, or other modalities; our dependence on key suppliers and manufacturers of specialized components, including those necessary for our trapped-ion quantum systems; our ability to scale production of our quantum computers and related systems; our ability to protect our intellectual property and proprietary technology; the significant research and development costs inherent in developing next-generation quantum computing capabilities; our ability to attract and retain highly skilled scientists, engineers and other personnel in a competitive labor market; changes in government funding, export controls, or regulations affecting quantum technologies; uncertainty regarding the timing and extent of commercial applications; cybersecurity risks and the protection of sensitive customer data; and macroeconomic conditions, geopolitical instability and their potential effects on our business and operations. For additional information on these and other risks that could affect the Company's forward-looking statements, see the Company's risk factors discussed in its filings with the U.S. Securities and Exchange Commission, as such risk factors may be updated from time to time. You should evaluate all forward-looking statements made in this press release in the context of these risks and uncertainties. The Company disclaims any intent or obligation to update, revise or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.
([1]) As of December 31, 2025.
Appendix
Condensed Consolidated Statements of Operations (Unaudited)
(dollars in thousands, except share and per share data)
Amounts may not sum Six Months Ended June
due to rounding. Three Months Ended June 30, 30,
----------------------- --------------------------- ----------------------
2026 2025 2026 2025
----------------------- ------------- ------------ ------------ --------
Revenue--net 7,998 2,108 13,235 21,193
Costs and expenses:
Cost of revenue 10,312 1,205 11,424 2,670
Amortization expense 4,185 2,839 8,370 5,678
Research and
development
expenses--net 367,292 39,667 421,951 75,440
Sales and marketing
expenses 29,328 3,413 43,064 6,802
General and
administrative
expenses 151,907 6,071 160,603 11,569
Total costs and
expenses 563,024 53,195 645,412 102,159
Loss from operations (555,026) (51,087) (632,177) (80,966)
Interest income--net (4,719) (999) (9,483) (2,343)
Loss on change in fair
value of warrant
liabilities 47,615 6,400 111,815 7,800
Other
(income)/expense--net (1,971) 429 (2,013) 800
Loss before taxes (595,951) (56,917) (732,496) (87,223)
Tax expense 569 -- 617 183
Net loss (596,520) (56,917) (733,113) (87,406)
Less: Net loss
attributable to
Quantinuum (Cayman)
prior to the
Transactions (110,087) N/A (246,680) N/A
Less: Net loss
attributable to the
non-controlling
interest (421,015) N/A (421,015) N/A
Net loss attributable
to Quantinuum Inc. (65,418) N/A (65,418) N/A
======================= ============= ============ ============ ========
Net loss per share
attributable to Class
A common
stockholders--basic
and diluted(1) (1.93) N/A (1.93) N/A
Weighted-average shares
used in computing net
loss per share
attributable to Class
A common
stockholders--basic
and diluted(1) 33,914,995 N/A 33,914,995 N/A
(1) Represents net loss per share of Class A common stock and weighted-average
shares of Class A common stock for the period from June 5, 2026 through June
30, 2026, which is the period effective with and following the Transactions as
defined in Note 1 -- Description of Organization. Refer to Note 14 -- Net
Earnings Per Share for additional details.
Condensed Consolidated Balance Sheets (Unaudited)
(dollars in thousands)
Amounts may not sum due to rounding. June 30, 2026 December 31, 2025
-------------------------------------------- ------------- -----------------
Assets
Current assets:
Cash and cash equivalents 2,106,686 762,642
Accounts receivable 3,348 5,068
Due from related parties 532 604
Net investment in lease, current 5,773 5,773
Other current assets 32,357 27,754
Total current assets 2,148,696 801,841
Property and equipment--net 150,611 120,965
Right-of-use assets 30,911 10,000
Goodwill 769,631 784,822
Other intangible assets--net 105,105 114,282
Net investment in lease, non-current 7,216 10,102
Prepayment to related parties, non-current 14,136 --
Other assets--net 3,665 3,613
Total assets 3,229,971 1,845,625
Liabilities
Current liabilities:
Accounts payable 29,393 10,620
Due to related parties 52 1,273
Accrued liabilities 109,286 44,358
Total current liabilities 138,731 56,251
Warrant liability -- 38,400
License payable, non-current portion 55,345 55,345
Operating lease liabilities, non-current 29,860 7,143
Other liabilities 681 893
Temporary equity
Series A convertible redeemable preferred
stock, $0.0001 par value per share;
31,983,034 shares authorized as of
December 31, 2025; 23,119,001 shares
issued and outstanding as of December 31,
2025; liquidation preference of $423,540
as of December 31, 2025 -- 288,129
Series A-1 convertible redeemable preferred
stock, $0.0001 par value per share;
28,016,966 shares authorized, issued and
outstanding as of December 31, 2025;
liquidation preference of $479,930,628 as
of December 31, 2025 -- 400,978
Series B convertible redeemable preferred
stock, $0.0001 par value per share;
31,753,266 shares authorized as of
December 31, 2025; 31,336,698 shares
issued and outstanding as of December 31,
2025; liquidation preference $878,367,645
as of December 31, 2025 -- 824,834
Shareholders' equity / Quantinuum (Cayman) equity
Quantinuum (Cayman) equity -- 173,652
Preferred stock, $0.0001 par value per
share; 20,000,000 shares authorized, as of
June 30, 2026; no shares issued and
outstanding as of June 30, 2026 -- --
Class A common stock, $0.0001 par value per
share; 2,000,000,000 shares authorized as
of June 30, 2026; 36,134,196 shares issued
and outstanding as of June 30, 2026 3 --
Class B common stock, $0.0001 par value per
share; 2,000,000,000 shares authorized as
of June 30, 2026; 226,771,877 shares issued
and outstanding as of June 30, 2026 23 --
Additional paid-in-capital 480,105 --
Accumulated other comprehensive (loss)
income (1,631) --
Accumulated deficit (65,418) --
Total equity attributable to Quantinuum Inc.
/ Quantinuum (Cayman) 413,082 173,652
Non-controlling interest 2,592,272 --
Total equity 3,005,354 173,652
Total liabilities and equity 3,229,971 1,845,625
============================================ ============= =================
Condensed Consolidated Statements of Cash Flows (Unaudited)
(dollars in thousands)
Six Months Ended June 30,
Amounts may not sum due to rounding. 2026 2025
------------- ------------
Cash flows from operating activities:
Net loss (733,113) (87,406)
Adjustments to reconcile to net cash used for operating activities
Depreciation and amortization 18,460 14,851
Noncash lease expense 230 1,395
Sales under sales-type lease -- (16,526)
Stock compensation expense 447,454 --
Loss on change in fair value of warrant
liabilities 111,815 7,800
(Gain)/Loss on disposal and write down of assets (10) 901
Interest expense 4 4
Foreign exchange (gain)/loss--net 62 (15)
Access to quantum computing hardware 4,648 2,991
Changes in operating assets and liabilities
Accounts receivable 1,690 1,843
Due from related parties 38 229
Other current assets (11,082) 565
Net investment in leases 2,886 2,886
Prepayment to related parties, non-current (14,136) --
Other assets--net 472 1,516
Accounts payable 15,463 4,387
Due to related parties (710) (534)
Accrued liabilities 26,943 (746)
Other liabilities (199) 79
Net cash used for operating activities (129,085) (65,780)
Cash flows from investing activities:
Capital expenditures (39,177) (37,721)
Net cash used for investing activities (39,177) (37,721)
Cash flows from financing activities:
Proceeds from issuance of common stock 1,628,774 --
Common stock issuance costs (23,534) --
Withholding taxes paid on stock compensation (91,984) --
Net cash provided by financing activities 1,513,256 --
Effect of exchange rate changes on cash and cash
equivalents (951) 23
Net increase (decrease) in cash and cash
equivalents 1,344,044 (103,478)
Cash and cash equivalents at beginning of period 762,642 172,343
Cash and cash equivalents at end of period 2,106,686 68,865
================================================= ============= ============
Non-cash investing and financing activities:
Unpaid purchases of property and equipment 9,227 8,348
Unpaid withholding taxes on stock compensation 38,692 --
Unpaid issuance costs 5,672 --
Value of shares issued via cashless warrant 150,215 --
exercise
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (Unaudited)
(dollars in thousands, except percentages)
Amounts may not
sum due to Three Months
rounding. Ended June 30, Six Months Ended June 30,
----------------- ----------------- ------------------------------------
2026 2025 2026 2025
----------------- ----------------- ------------- ------------- ------
Revenue, net 7,998 2,108 13,235 21,193
Cost of revenue 10,312 1,205 11,424 2,670
Amortization of
acquired
intangibles,
cost of revenue
portion(1) 2,839 2,839 5,679 5,679
GAAP gross profit (5,153) (1,936) (3,868) 12,844
GAAP gross
margin (64.4 %) (91.8 %) (29.2 %) 60.6 %
Add back: Equity
compensation
and related
employer
taxes(2) 6,573 -- 6,573 --
Add back:
Depreciation
and
amortization(3) 3,515 3,249 7,039 6,579
Adjusted gross
profit 4,935 1,312 9,744 19,423
================= ================= ============= ============= ======
Adjusted gross
margin 61.7 % 62.3 % 73.6 % 91.6 %
(1) Our condensed consolidated statements of operations present amortization of acquired intangibles as a single separate line and do not present a gross profit subtotal. The amount shown in this table is the portion of that line attributable to cost of revenue, allocated according to the assets to which it relates. Cost of revenue is presented as reported. The remaining portion is presented within research and development.
(2) Represents stock-based compensation expense and the related employer payroll taxes on equity vesting, in each case attributable to cost of revenue. Employer payroll taxes were 242 and 242 for the three and six months ended June 30, 2026, respectively, and 0 in the corresponding prior year periods. These amounts are a subset of the equity compensation and related employer taxes adjustment presented in the reconciliation of GAAP net loss.
(3) Represents depreciation of property and equipment and amortization of acquired intangible assets attributable to cost of revenue.
Reconciliation of GAAP Net Loss to Adjusted Net Loss, Adjusted EBITDA and
Adjusted Earnings Per Share (Unaudited) (dollars in thousands, except share
and per share amounts)
Amounts may not
sum due to
rounding. Three Months Ended June 30, Six Months Ended June 30,
----------------------------- ---------------------------
2026 2025 2026 2025
---------------- ----------- --------------- ----------
Numerator
Net loss
attributable to
Quantinuum Inc. (65,418) N/A (65,418) N/A
Less: Net loss
attributable to
Quantinuum
(Cayman) prior
to the
Transactions (110,087) N/A (246,680) N/A
Less: Net loss
attributable to
the
non-controlling
interest (421,015) N/A (421,015) N/A
GAAP net loss,
as-converted(1) (596,520) (56,917) (733,113) (87,406)
Add back: income
tax expense 569 -- 617 183
Equity
compensation and
related employer
taxes(2) 464,587 -- 464,587 --
IPO readiness,
legal and other
transaction
costs(3) 10,620 -- 19,801 --
Warrant fair
value
adjustment 47,615 6,400 111,815 7,800
Loss on disposal
and write down
Comments